Cancer Cells Transfer Mitochondria to Neighboring Cells to Support Tumor Growth

Scientists at ETH Zurich have discovered that cancer cells transfer mitochondria to neighboring healthy cells, transforming their behavior and promoting tumor growth. This novel mechanism offers potential new targets for cancer therapy.
Research conducted at ETH Zurich has uncovered a novel mechanism by which cancer cells actively transfer their mitochondria to nearby healthy connective tissue cells, known as fibroblasts. This mitochondrial transfer enables the fibroblasts to transform into tumor-associated fibroblasts that significantly support tumor progression. The process involves tiny membrane tubes that function similarly to pneumatic systems, allowing mitochondria to be transported from cancer cells into adjacent cells.
This transfer reprograms the fibroblasts, causing them to multiply faster, produce more ATP (the cell's energy currency), and secrete elevated levels of growth factors and cytokines—all of which foster a more aggressive tumor environment. Moreover, these altered fibroblasts modify the extracellular matrix, increasing tissue components that further facilitate tumor growth.
The discovery was serendipitous, originating from observing cell connections between cancer and fibroblast cells in petri dish cultures. The research revealed that mitochondria can be exchanged bidirectionally—an insight that was previously limited to unidirectional transfer from healthy cells to damaged nerve cells after strokes. The findings suggest that tumors exploit this cellular communication for their survival and expansion.
Additionally, the study identified the protein MIRO2 as a crucial molecule mediating the transfer of mitochondria. High levels of MIRO2 were observed in cancer cells involved in mitochondrial transfer, especially at tumor edges where cells invade healthy tissue. Blocking MIRO2 in laboratory and animal models inhibited mitochondrial transfer and prevented fibroblasts from becoming tumor-promoting, indicating potential therapeutic targets.
While these results are promising, further research is needed to develop inhibitors that can effectively block MIRO2 in humans without adverse effects. If successful, such therapies could slow down or halt tumor growth by interrupting these mitochondrial exchanges. Overall, this study highlights a sophisticated method tumors use to manipulate their environment and offers new avenues for cancer treatment.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Identifies Common Long COVID Symptoms in Young Children
A new study reveals key long COVID symptoms in young children, including sleep issues, fussiness, poor appetite, and cough, highlighting the need for tailored care strategies for this age group.
Impact of the Great Irish Famine on Human Height Explored by New Research
New research explores how the Great Irish Famine affected human height, revealing insights into survival and health long-term effects of humanitarian disasters.
Transforming Global Health: Moving Beyond Grant-Dependent Systems
A groundbreaking study highlights the need to overhaul grant-dependent funding models in global health, advocating for systemic change to promote equity and true decolonization.
Global Estimates Reveal 74,000 Children Born Annually with Hepatitis C
A new study estimates that 74,000 children are born with hepatitis C each year worldwide, highlighting the need for increased screening and treatment to prevent mother-to-child transmission.